Erratum: Immunomodulators in COVID-19: Two Sides to Every Coin (American Journal of Respiratory and Critical Care Medicine (2020) 202 (1460–1462) DOI: 10.1164/rccm.202008-3148LE)

Scott E. Evans, Jezreel Pantaleón García, Burton F. Dickey

Research output: Contribution to journalComment/debatepeer-review

Abstract

There is an error in the letter by Snow and colleagues (1), published in the November 15, 2020, issue of the Journal. In Figure 1, the drug PUL-042 is incorrectly indicated as an inhibitor of Toll-like receptors 2/6/9 (TLR-2/6/9), when in fact it is comprised of agonists of the TLR-2/6 heterodimer and the TLR-9 homodimer. A corrected version of the figure is included here. The authors thank Drs. Scott E. Evans, Jezreel Pantale´on Garc´ia, and Burton F. Dickey from the University of Texas MD Anderson Cancer Center, who alerted the Journal to the error.

Original languageEnglish (US)
Pages (from-to)782-783
Number of pages2
JournalAmerican journal of respiratory and critical care medicine
Volume203
Issue number6
DOIs
StatePublished - Mar 15 2021

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine
  • Critical Care and Intensive Care Medicine

Fingerprint

Dive into the research topics of 'Erratum: Immunomodulators in COVID-19: Two Sides to Every Coin (American Journal of Respiratory and Critical Care Medicine (2020) 202 (1460–1462) DOI: 10.1164/rccm.202008-3148LE)'. Together they form a unique fingerprint.

Cite this